Such an important outcome from this FDA meeting going forward.
Info on pivotal meeting
Primary/ secondary end points decided
Number of patients required in the trial
Time-line of the trial.
To see a confident Jon following the release of meeting results on required achievable ends points, with low number of patients, on a short time-line, will mean getting the therapy out to the families quicker. — An outcome everyone wants .
Tying in Jons decision of a buy-back to counter-acts potential big pharma shenanigans, I am confident the outcome will be positive on all three fronts.
NEU Price at posting:
$12.55 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)